# FDA Inspection 1073775 - Biomat USA, Inc. - October 26, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e7ba7945-e849-467a-8364-6fbbad9c4cf8
Source feed: FDA_Inspections

> FDA Inspection 1073775 for Biomat USA, Inc. on October 26, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1073775
- Company Name: Biomat USA, Inc.
- Inspection Date: 2018-10-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 849741 - 2013-09-24](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/40c07776-1e6f-4412-82ee-7c7a4b15060e)
- [FDA Inspection 731857 - 2011-06-23](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/09d9a559-7ea6-4a45-ae3e-9192b92a9010)

Company: https://www.keypedia.com/companies/biomat-usa-inc/61fbe50e-5481-4b4e-94eb-f2dbe12a0b33

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d